Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph W Moss

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Integrative Cancer Therapies|January 1, 2009
Enzymes, trophoblasts, and cancer: the afterlife of an idea (1924-2008)Ralph W Moss
Lancet (London, England)|April 9, 2002
Preoperative and postoperative radiotherapy and survival in colorectal cancerRalph W Moss
Pharmacological Research|November 9, 2013
Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunityShimon Slavin, Ralph W Moss, Tibor Bakacs
Immunobiology|August 9, 2011
Ipilimumab (Yervoy) and the TGN1412 catastropheTibor Bakacs, Jitendra N Mehrishi, Ralph W Moss
Pharmacological Research|April 17, 2012
Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)Tibor Bakacs, Jitendra N Mehrishi, Miklós Szabó, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2020
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapiesCsaba Kerepesi, Tibor Bakacs, Ralph W Moss, et al.
Integrative Cancer Therapies|October 10, 2009
Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 casesXiaohuai Wang, Weimin Zhang, Zhiyong Xu, et al.
Scandinavian Journal of Immunology|October 8, 2019
Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancerTibor Bakacs, Ralph W Moss, Ralf Kleef, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Integrative Cancer Therapies|January 1, 2009
Enzymes, trophoblasts, and cancer: the afterlife of an idea (1924-2008)Ralph W Moss
Lancet (London, England)|April 9, 2002
Preoperative and postoperative radiotherapy and survival in colorectal cancerRalph W Moss
Pharmacological Research|November 9, 2013
Control of minimal residual cancer by low dose ipilimumab activating autologous anti-tumor immunityShimon Slavin, Ralph W Moss, Tibor Bakacs
Immunobiology|August 9, 2011
Ipilimumab (Yervoy) and the TGN1412 catastropheTibor Bakacs, Jitendra N Mehrishi, Ralph W Moss
Pharmacological Research|April 17, 2012
Interesting possibilities to improve the safety and efficacy of ipilimumab (Yervoy)Tibor Bakacs, Jitendra N Mehrishi, Miklós Szabó, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2020
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapiesCsaba Kerepesi, Tibor Bakacs, Ralph W Moss, et al.
Integrative Cancer Therapies|October 10, 2009
Sonodynamic and photodynamic therapy in advanced breast carcinoma: a report of 3 casesXiaohuai Wang, Weimin Zhang, Zhiyong Xu, et al.
Scandinavian Journal of Immunology|October 8, 2019
Exploiting autoimmunity unleashed by low-dose immune checkpoint blockade to treat advanced cancerTibor Bakacs, Ralph W Moss, Ralf Kleef, et al.
Pageof 2